Additional Proxy Soliciting Materials (definitive) (defa14a)
April 28 2017 - 7:32AM
Edgar (US Regulatory)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒ Filed by a Party other than the
Registrant ☐
Check the appropriate box:
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
☐
|
|
Soliciting Material Pursuant to § 240.14a-12
|
KITE
PHARMA, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box)
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
1.
|
|
Title of each class of securities to which transaction applies:
|
|
|
2.
|
|
Aggregate number of securities to which transaction applies:
|
|
|
3.
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
4.
|
|
Proposed maximum aggregate value of transaction:
|
|
|
5.
|
|
Total fee paid:
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
6.
|
|
Amount Previously Paid:
|
|
|
7.
|
|
Form, Schedule or Registration Statement No.:
|
|
|
8.
|
|
Filing Party:
|
|
|
9.
|
|
Date Filed:
|
***
Exercise Your Right to Vote *** Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held on <mtgdate>. June 20, 2017 KITE PHARMA, INC. Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica, CA 90404
Meeting Information Meeting Type: Annual <mtgtype> Meeting For holders as of: April <recdate> 24, 2017 Date: June 20, 2017 Time: 8:00 <mtgtime> AM EST Location: Kite Pharma, Inc. 689 Fifth Avenue, 14th Floor New York, New York
10022 You are receiving this communication because you hold shares in the above named company. This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials
that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy
materials before voting. See the reverse side of this notice to obtain proxy materials and voting instructions. 0000336398_1 R1.0.1.15
Before You
Vote How to Access the Proxy Materials Proxy Materials Available to VIEW or RECEIVE: 1. Notice & Proxy Statement 2. Form
10-K
How to View Online: Have the information that is
printed in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com. How to Request and Receive a PAPER or
E-MAIL
Copy: If you want to receive a paper or
e-mail
copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request: 1) BY INTERNET: www.proxyvote.com 2) BY TELEPHONE:
1-800-579-1639
3) BY
E-MAIL*:
sendmaterial@proxyvote.com * If requesting materials by
e-mail,
please send a blank
e-mail
with the information that is printed in the box marked by the arrow? (located on the following page) in the subject line. Requests,
instructions and other inquiries sent to this
e-mail
address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 06, 2017 to facilitate timely
delivery. How To Vote Please Choose One of the Following Voting Methods Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the
meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Vote By Internet: To vote now by Internet,go to www.proxyvote.com. Have the
information that is printed in the box marked by the arrow ? available and follow the instructions. Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
Voting
items The Board of Directors recommends you vote FOR the following: 1. Election of Directors to hold office until the 2020 Annual Meeting of Stockholders Nominees 01
Mr. Franz B. Humer 02 Mr. Joshua A. Kazam 03 Mr. Steven B. Ruchefsky The Board of Directors recommends you vote FOR the following proposal: 2. To ratify the selection of Ernst & Young LLP
as the independent registered public accounting firm for the fiscal year ending December 31, 2017. The Board of Directors recommends you vote AGAINST the following proposal: 3. To consider the
stockholder proposal entitled Elect Each Director Annually. The Board of Directors recommends you vote FOR the following proposal: 4. To approve, on an advisory basis, the compensation of the
Companys named executive officers, as disclosed in the proxy statement. The Board of Directors recommends you vote 1 YEAR on the following proposal: 5. To indicate, on an advisory basis,
the preferred frequency of future stockholder advisory votes on the compensation of the Companys named executive officers. NOTE: In their discretion,
the proxies are authorized to vote upon such other business as may properly come before the Annual Meeting or any adjournment thereof. This proxy, when properly executed, will be voted as directed herein by the undersigned stockholder. If no
direction is made, this proxy will be voted FOR ALL in Proposal 1, FOR in Proposal 2, AGAINST in Proposal 3, FOR in Proposal 4 and for 1 YEAR in proposal 5. 0000336398_3 R1.0.1.15
0000336398_4 R1.0.1.15
KITE PHARMA, INC. (NASDAQ:KITE)
Historical Stock Chart
From Mar 2024 to Apr 2024
KITE PHARMA, INC. (NASDAQ:KITE)
Historical Stock Chart
From Apr 2023 to Apr 2024